Archive for 2019
Multiple California Counties Warn Parents About Deadly Fake Pills After the Deaths of Two Teens in Santa Clara County
On September 30th, the Public Health Department of Santa Clara County, California updated a public health warning they had issued September 10th about deadly counterfeit 30mg oxycodone pills. The initial warning described “tablets visually appear to be the pharmaceutically manufactured version—they are circular in shape, light blue to light green in color, and have an ‘M’ inside a square stamped on one side and a ‘30’ stamped on the other side. Numerous fatal overdoses have been tied to these tablets, with a strong uptick in fatal overdoses in August 2019.”
[...]Former Pennsylvania Congressman Decries Fake Drug Sales Via Social Media
This editorial by Ryan Costello was published in The Philadelphia Enquirer on October 9, 2019. Mr. Costello is a former U.S. Congressman (PA-06), and is now a public policy consultant.
[...]Emory Health Policy Professor Says Drug Importation a Danger to Patient Health
This editorial by Dr. Kenneth E. Thorpe was published in Town Hall on October 8, 2019. Dr. Thorpe is a professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.
[...]Beloved Mother Slain by a Colorado Counterfeit Drug Trade
32-year-old Grand Junction resident Ashley Romero was the cherished eldest daughter of her close-knit Colorado family. With her warm heart and brilliant, 1,000 watt smile, she made friends everywhere she went. Ashley died on June 11, 2018, after taking half of an oxycodone pill. The pill was fake and actually made with fentanyl.
[...]PSM Member Spotlight: NeedyMeds
In a new series highlighting the good works done by our member organizations for their own causes, PSM spoke with Dr. Rich Sagall about NeedyMeds, the nonprofit he founded to Americans who are struggling to pay for their medications and other healthcare costs…
[...]PSM, Partners Host Fall 2019 Congressional Briefings About Counterfeit Drug Dangers
On September 24, 2019, the Partnership for Safe Medicines and 19 partner organizations held two congressional briefings about the real dangers counterfeit drugs pose to Americans, offering a clear picture of why importation cannot solve the problem of high drug prices in the U.S.:
Canada does not have enough prescription drugs to share with U.S.patients, and organized crime is poised to expand the counterfeit drug trade into the U.S. to bridge the gap without regard for the health and safety of U.S. residents. “The money to be made is far too great to worry about human life.”
[...]Ophthalmologist in Florida Investigated for Using Counterfeit Botox on Patients
A Coral Gables, Florida ophthalmologist at the Beautiful Vision Clinic is being investigated for importing counterfeit Botox from China to use on patients. On September 11, 2019, investigators raided the office of Dr. Francesann Ford and seized boxes of Botox that they allege are counterfeits imported from China.
[...]Myth: We are getting the same drugs Canadians take
In 2014, during a two-year period when Maine was experimenting with drug importation, the president of Maine’s Pharmacy Association purchased medications from an online pharmacy for testing. The drugs he received were not approved for the Canadian or U.S. markets. Worse, they were poor quality: two of them were the wrong strength, and the other was contaminated.
[...]Two Studies Confirm Drug Importation Would Decimate The Canadian Drug Supply
Two new studies recently published in Canadian Health Policy each reached the same conclusion: legalizing drug importation in the U.S. would cause catastrophic damage to the Canadian drug supply…
[...]Pharmacy professor: buying prescription drugs from Canada “risky in terms of quality and safety”
This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.
[...]